King Pharmaceuticals KG Unrealized losses of unrealized loss positions
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:InvestmentsContinuousUnrealizedLossPositionAccumulatedLoss.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's unrealized losses of unrealized loss positions.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's unrealized losses of unrealized loss positions?
- King Pharmaceuticals (KG) reported unrealized losses of unrealized loss positions of $484K in Q1 2026.